Brakewood Harold Eugene 4

What Happened

• Harold Eugene Brakewood, Chief Business Officer of Immuneering Corp (IMRX), made an open-market purchase of 5,250 shares on January 16, 2026. The shares were acquired at $4.76 per share for a total purchase price of $24,990. This was a straight purchase (transaction code P), which investors often view as a mild bullish signal compared with sales.

Key Details

• Transaction date and price: 2026-01-16, 5,250 shares at $4.76 each.
• Total value: ~$24,990.
• Transaction type: Open market purchase (code P).
• Shares owned after transaction: Not specified in the provided summary; see the filed Form 4 for exact post-transaction holdings.
• Filing date: Form 4 filed 2026-01-21. This filing appears to be within the two-business-day SEC deadline (Jan 20–21 accounting for the MLK holiday), so it was timely.
• No option exercises, gifts, tax withholding, or 10b5-1 plan referenced in the provided transaction details.

Context

• The purchase size is modest (~$25k) relative to typical insider trades; while purchases can be informative, a single small open-market buy is only one data point and does not alone indicate a material change in insider sentiment or company prospects. For full details (post-transaction holdings, exact filing language), consult the full Form 4 (Accession No. 0001790340-26-000016).